Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the google-analytics-for-wordpress domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home2/owwrxnte/public_html/wp-includes/functions.php on line 6121
Simurx – Simurx Skip to content

INNOVATIVE CELLULAR THERAPIES TO TREAT SOLID TUMORS

Revolutionizing Solid Tumor Treatment by Turning Tumor
Defenses Into CAR T Cell Strengths

INNOVATIVE CELLULAR THERAPIES TO
TREAT SOLID TUMORS

Revolutionizing Solid Tumor Treatment by Turning Tumor Defenses Into
CAR T Cell Strengths.

Who We Are

At Simurx, we are driven by a deep commitment to scientific excellence and an unwavering determination to enhance outcomes for cancer patients. Our team of scientists has pioneered the CTSR platform, a groundbreaking technology that harnesses the immunosuppressive properties of the tumor microenvironment to significantly improve the efficacy of cell therapies. This innovation is protected by a comprehensive patent portfolio.

Our multidisciplinary and integrative approach to product development ensures that we remain at the forefront of cancer therapy innovation. With our cutting-edge technology, Simurx is uniquely positioned to deliver a wide range of multifunctional CAR T-cell therapies, offering new hope to cancer patients around the world.

our-platform-358x258

Our Platform

Our patented chimeric TGFβ-signaling receptor (CTSR) platform promotes survival in a hostile tumor environment and can be modularly combined with other engineered cell therapies

the-science-358x258

The Science

The CTSR platform soaks up immunosuppressive molecules from the tumor microenvironment while promoting CAR-T proliferation and immune activation.

our-pipline-358x258

Our Pipeline

The modular design and inherent flexibility of the CTSR platform allow its incorporation into a multitude cellular therapies

Latest News

 

Corporate HQ

2265 E Foothill Blvd
Pasadena, California 91107
United States

Contact

Phone: (310) 629-0476
Fax: (310) 361-6903